Company

Eisai and Siemens Healthineers Sign Strategic Cooperation Agreement at CIIE – Advancing Precision Imaging in Alzheimer's Disease Diagnosis and Treatment
EisaiETR: SHL

Eisai and Siemens Healthineers Sign Strategic Cooperation Agreement at CIIE – Advancing Precision Imaging in Alzheimer’s Disease Diagnosis and Treatment

Eisai Co., Ltd. (TYO: 4523) and Siemens Healthineers AG (ETR: SHL) officially signed a strategic cooperation agreement during the 9th China International Import Expo (CIIE). The two parties announced that…

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform

Viatris Reports Stable Q3 2026 Results with Enhanced Profitability – Raises Full‑Year Guidance as Pacira BioSciences Acquisition Nears Completion

Viatris Reports Stable Q3 2026 Results with Enhanced Profitability – Raises Full‑Year Guidance as Pacira BioSciences Acquisition Nears Completion

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Harbour BioMed Licenses HAT001/HBM9013 to Global Partner for CRH-Targeted Therapy
BiotechHarbour BioMed

Harbour BioMed Licenses HAT001/HBM9013 to Global Partner for CRH-Targeted Therapy

Basecare and Rhea Labs Form Five-Year Alliance to Expand IVF Markets Globally
Basecare MedicalHKG: 2170

Basecare and Rhea Labs Form Five-Year Alliance to Expand IVF Markets Globally

Takeda Partners with BridGene to Develop Immunology and Neurology Drug Candidates
BridGene BiosciencesNYSE: TAK

Takeda Partners with BridGene to Develop Immunology and Neurology Drug Candidates

Hansoh Pharmaceutical's HS-10561 Receives NMPA Clearance for Chronic Spontaneous Urticaria
Clinical trial approval / initiationHansoh Pharmaceutical

Hansoh Pharmaceutical’s HS-10561 Receives NMPA Clearance for Chronic Spontaneous Urticaria

Show More